Article PDF
References
Dodge RR, Burrows B: The prevalence and incidence of asthma and asthmalike symptoms in a general population sample. Am Rev Respir Dis 122:567–574, 1980
Speizer FE: Epidemiology and mortality patterns in asthma. In Weiss EB (ed): Status asthmaticus. Baltimore, University Park Press, 1978, pp 13–18
Williams H, McNicol KN: Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children: An epidemiological study. Br Med J 4:321–325, 1969
Downes JJ, Heiser MS: Status asthmaticus in children. In Gregory GA (ed): Respiratory failure in the child. New York, Churchill Livingstone, 1981, pp 107–133
Leffert F: Management of acute severe asthma. J Pediatr 96:1–12, 1980
Mansmann HC Jr: A 25-year perspective of status asthmaticus. Clin Rev Allergy 1:147–162, 1983
Siegel RL, Twarog FJ: Emergency room therapy of the pediatric patient with status asthmaticus. J Asthma 19:47–52, 1982
National Center for Health Statistics: Vital statistics of the United States—mortality, 1968-1978. Hyattsville, Md., NCHS, annual
Arnold AG, Lane DJ, Zapata E: The speed of onset and seventy of acute severe asthma. Br J Dis Chest 76:157–163, 1982
Buranakul B, Washington J, Hilman B, Mancuso J, Sly RM: Causes of death during acute asthma in children. Am J Dis Child 128:343–350, 1974
McDonald JB, Seaton A, Williams DA: Asthma deaths in Cardiff 1963–74: 90 deaths outside hospital. Br Med J 1:1493–1495, 1976
Simons FER, Pierson WE, Bierman CW: Respiratory failure in childhood status asthmaticus. Am J Dis Child 131:1097–1101, 1977
Boushey HA, Holtzman MJ, Sheller JR, Nadel JA: Bronchial hyperreactivity. Am Rev Respir Dis 121:389–413, 1980
Altman LC: Basic immune mechanisms in immediate hypersensitivity. Med Clin North Am 65:941–957, 1981
Austen KF: Tissue mast cells in immediate hypersensitivity. Hosp Pract 17:98–108, 1982
Wasserman SI: Mediators of immediate hypersensitivity. J Allergy Clin Immunol 72:101–118, 1983
Leff A: Pathophysiology of asthmatic bronchoconstriction. Chest 82(1 Suppl):13S-21S, 1982
Middleton E, Jr, Atkins FM, Fanning M, Georgitis JW: Cellular mechanisms in the pathogenesis and pathophysiology of asthma. Med Clin North Am 65:1013–1031, 1981
McFadden ER Jr: Pathogenesis of asthma. J Allergy Clin Immunol 73:413–424, 1984
Williams MH Jr: Expiratory flow rates: Their role in asthma therapy. Hosp Pract 17:95–110, 1982
Levison H, Tabachnik E, Newth CJL: Wheezing in infancy, croup and epiglottitis. Curr Probl Pediatr 12:1–65, 1982
Myers JR: Histamine receptors in the lungs. Chest 82:133, 1982
Schachter EN, Brown S, Lach E, Gerstenhaber B: Histamine blocking agents in healthy and asthmatic subjects. Chest 82:143–147, 1982
Brooks SM, McGowan K, Bernstein IL, Altenau P, Peagler J: Relationship between numbers of beta adrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol 63:401–406, 1979
Barnes PJ, Dollery CT, MacDermot J: Increased pulmonary a-adrenergic and reduced (3-adrenergic receptors in experimental asthma. Nature 285:569–571, 1980
Henderson WR, Shelhamer JH, Reingold DB, Smith LJ, Evans R III, Kaliner M: Alpha-adrenergic hyper-responsiveness in asthma. N Engl J Med 300:642–647, 1979
Simonsson BG, Svedmyr N, Skoogh BE, Andersson R, Bergh NP: In vivo and in vitro studies on alpha-receptors in human airways. Potentiation with bacterial endotoxin. Scand J Respir Dis 53:227–236, 1972
Barnes PJ, Skoogh BE, Brown JK, Nadel JA: Activation of a-adrenergic response in tracheal smooth muscle: A postreceptor mechanism. J Appl Physiol 54:1469–1476, 1983
Harries MG, Parkes PEG, Lessof MH, Orr TSC: Role of bronchial irritant receptors in asthma. Lancet 1:5–7, 1981
Gold WM: The role of the parasympathetic nervous system in airways disease. Postgrad Med J 51(Suppl 7): 53–62, 1975
Weissman G: The eicosanoids of asthma. N Engl J Med 308:454–456, 1983
Griffin M, Weiss JW, Leitch AG, McFadden ER, Grey EJ, Austen KF, Drazen JM: Effects of leukotriene D on the airways in asthma. N Engl J Med 308:436–439, 1983
Peress L, Sybrecht G, Macklem PT: The mechanism of increase in total lung capacity during acute asthma. Am J Med 61:165–169, 1976
Woolcock AJ, Read J: Lung volumes in exacerbations of asthma. Am J Med 41:259–273,1966
Permutt S: Physiologic changes in the acute asthmatic attack. In Ausken KF, Lichtenstein LM (eds): Asthma: Physiology, immunopharmacology, and treatment. Orlando, FL, Academic, 1973, pp 15–27
Roussos C, Macklem PT: The respiratory muscles. N Engl J Med 307:786–797, 1982
Ledbetter MK, Bruck E, Farhi LE: Perfusion of the underventilated compartment of the lungs in asthmatic children. J Clin Invest 43:2233–2240, 1964
Downes JJ, Wood DW, Striker TW, Pittman JC: Arterial blood gas and acid base disorders in infants and children with status asthmaticus. Pediatrics 42:238–249, 1968
Simpson H, Forfar JO, Grubb DJ: Arterial blood gas tensions and pH in acute asthma in childhood. Br Med J 3:460–464, 1968
Weng TR, Langer HM, Featherby EA, Levison H: Arterial blood gas tensions and acid-base balance in symptomatic and asymptomatic asthma in childhood. Am Rev Respir Dis 101:274–282, 1970
Eldridge F: Anaerobic metabolism of the respiratory muscles. J Appl Physiol 21:853–857, 1966
Appel D, Rubenstein R, Schrager K, Williams MH Jr: Lactic acidosis in severe asthma. Am J Med 75:580–584, 1983
Gluck JC, Busto R, Marks MB: Pulsus paradoxus in childhood asthma—Its prognostic value. Ann Allergy 38:405–407, 1977
Rebuck AJ, Tomarken JL: Pulsus paradoxus in asthmatic children. Can Med Assoc J 112:710–711, 1975
Fischl MA, Pitchenik A, Gardner LB: An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med 305:783–789, 1981
McGregor M: Pulsus paradoxus. N Engl J Med 301:480–482, 1979
Commey JO, Levison H: Physical signs in childhood asthma. Pediatrics 58:537–541, 1976
Edmunds AT, Godfrey S: Cardiovascular response during severe acute asthma and its treatment in children. Thorax 36:534–540, 1981
McIntosh K, Ellis EF, Hoffman LS, Lybass TG, Eller JJ, Fulginiti VA: The association of viral and bacterial respiratory infections with exacerbation of wheezing in young asthmatic children. J Pediatr 82:579–590, 1973
Wood DW, Downes JJ, Leeks HI: A clinical scoring system for the diagnosis of respiratory failure. Am J Dis Child 123:227–228, 1972
Pierson WE, Bierman CW, Kelley VC: A double-blind trial of corticosteroid therapy in status asthmaticus. Pediatrics 54:282–288, 1974
McFadden ER Jr, Lyons HA: Arterial-blood gas tension in asthma. N Engl J Med 278:1027–1032, 1968
West JB: Ventilation-perfusion and diffusion disturbance in asthma. In Weiss EB, Segal MS (eds): Bronchial asthma: Mechanism and therapeutics. Boston, Little Brown, 1976, pp 295–316
Wagner PD, Dantzker DR, Iacovoni VE, Tomlin WC, West JB: Ventilaton-perfusion inequality in asymptomatic asthma. Am Rev Respir Dis 118:511–524, 1978
Martin TG, Elenbaas RM, Pingleton SH: Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma. Ann Emerg Med 11:70–73, 1982
Smith TF, Hudgel DW: Decreased ventilation response to hypoxia in children with asthma. J Pediatr 97:736–741, 1980
Morrill CG, Dickey DW, Cropp GJA: Ventilatory response and drive of asthmatic children to alveolar hypoxia. Pediatr Res 15:1520–1524, 1981
Horowitz LN, Spear JF, Moore EN, Rogers R: Effects of aminophylline on the threshold for initiating ventricular fibrillation during respiratory failure. Am J Cardiol 35:376–379, 1975
Collins J, McDevitt D, Shanks R, Swanton J: The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol 36:35–45, 1969
Straub PW, Buhlman AA, Rossier PH: Hypovolemia in status asthmaticus. Lancet 2:923–926, 1969
Stalcup AS, Mellins RB: Mechanical forces producing pulmonary edema in acute asthma. N Engl J Med 297:592–596, 1977
Baker JW, Yerger S, Segar WE: Elevated plasma antidiuretic hormone levels in status asthmaticus. Mayo Clin Proc 51:31–34, 1976
Benfield GFA, O’Dohesry K, Davies BH: Status asthmaticus and the syndrome of inappropriate secretion of antidiuretic hormone. Thorax 37:147–148, 1982
Levi J, Coburn J, Kleeman CR: Mechanism of the antidiuretic effect of β-adrenergic stimulation in man. Arch Intern Med 136:25–29, 1976
Mithoefer JC, Runser RH, Karetzky MS: The use of sodium bicarbonate in the treatment of acute bronchial asthma. N Engl J Med 272:1200–1203, 1965
Gerst PH, Fleming WH, Malm JR: A quantitative evaluation of the effects of acidosis and alkalosis upon the ventricular fibrillation threshold. Surgery 59:1050–1060, 1966
Menitor SM, Goldring RM: Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med 74:898–901, 1983
Lulla S, Newcomb RW: Emergency management of asthma in children. J Pediatr 97:346–350, 1980
Lyons HA: Bronchodilator adrenergic therapy. In Weiss EG, Segal MS (eds): Bronchial asthma: Mechanisms and therapeutics. Boston, Little Brown, 1976, pp 727–737
Ahlquist RP: A study of adrenotropic receptors. Am J Physiol 153:586–600, 1948
Lands AM, Arnold A, McAuliff J, et al: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597–598, 1967
McFadden ER: Beta2 receptor agonists: Metabolism and pharmacology. J Allergy Clin Immunol 68:91–97, 1981
Brittain RT, Jack D: Recent work on selective beta-adrenoceptor stimulants. In Weiss EB, Segal MS (eds): Bronchial asthma—Mechanisms and therapeutics. Boston, Little Brown, 1976, pp 739–748
Becker AB, Nelson NA, Simons FER: Inhaled salbutamol (albuterol) vs. injected epinephrine in the treatment of acute asthma in children. J Pediatr 102:465–469, 1983
Thompson P, Friedman M: Intramuscular salbutamol in treatment of acute exacerbations of childhood asthma. Arch Dis Child 52:551–554, 1977
Sly RM, Badier B, Faciane J: Comparison of subcutaneous terbutaline with epinephrine in the treatment of asthma in children. J Allergy Clin Immunol 59:128–135, 1977
Bierman CW: Adrenergic drugs. Clin Rev Allergy 1:87–104, 1982
Garra B, Shapiro GG, Dorsett CS, Simons FER, Pierson WE, Bierman CW: A double-blind evaluation of the use of nebulized metaproterenol and isoproterenol in hospitalized asthmatic children and adolescents. J Allergy Clin Immunol 60:63–68, 1977
Lenney W: Nebulized salbutamol in treatment of acute asthma in children. Lancet 1:440–441, 1978
Bacon CJ: Nebulized salbutamol in treatment of acute asthma in children. Lancet 1:158, 1978
Tabachnik E, Levison H: Clinical application of aerosols in pediatrics. Am Rev Respir Dis 122(part 2):97–103, 1980
Swift DL: Generation and respiratory deposition of therapeutic aerosols. Am Rev Respir Dis 122(part 2):71–77, 1980
Shaw RJS, Waller JF, Hetzel MR, Clark TJH: Do oral and inhaled terbutaline have different effects on the lung? Br J Dis Chest 76:171–176, 1982
Murray AB, Hardwick DE, Pirie GE, Fraser BM: The effects of pressurized isoproterenol and salbutamol in asthmatic children. Pediatrics 54:746–756, 1974
Godfrey S: Worldwide experience with albuterol (salbutamol). Ann Allergy 47:423–426, 1981
Lenney W, Milner AD: At what age do bronchodilators work? Arch Dis Child 53:532–535, 1978
Jones RS: Management of asthma in the child aged under 6 years. Br Med J 282:1914–1916, 1981
Ellis EF: Theophylline. Clin Rev Allergy 1:73–85, 1983
Hendeles L, Weinberger M: Theophylline: A “state of the art” review. Pharmacotherapy 3:2–44, 1983
Weinberg M: The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 73:525–540, 1984
Hendeles L, Weinberger M, Bighley L: Absolute bioavailability of oral theophylline. Am J Hosp Pharm 34:525–527, 1977
Bergstrand H: Phosphodiesterase inhibition and theophylline. Eur J Respir Dis 61(Suppl 109):37–44, 1980
Horrobin DF, Manku MS, Franks DJ: Methylxanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. Prostaglandins 13:33–40, 1977
Miech RP, Niedzwicki JG, Smith TR: Effect of theophylline on the binding of cAMP to soluble protein from tracheal smooth muscle. Biochem Pharmacol 28:3687–3688, 1979
Brisson GR, Malaisse-Lagae F, Malaisse WJ: The stimulus-secretion coupling of glucose-induced insulin release. VII. A proposed site of action for adenosine 3′5′-cyclic monophosphate. J Clin Invest 51:232–241, 1972
Abramowitz PW, Perez MM, Johnson CE, McClean JA: Effect of theophylline, terbutaline and their combination on the immediate hypersensitivity skin test reaction. J Allergy Clin Immunol 66:123–128, 1980
Martin GL, Atkins PC, Dunsky EH, Zweiman B: Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol 66:204–212, 1980
Levy G, Koysooko R: Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr 86:789–793, 1975
Loughnan PG, Sitar DS, Ogilvie RI, Eisen A, Fox Z, Neims AH: Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 88:874–879, 1976
Ellis EF, Koysooko R, Levy G: Pharmacokinetics of theophylline in children with asthma. Pediatrics 58:542–547, 1976
Goldberg P, Leffert F, Gonzalez M, Gogenola L, Zerbe GO: Intravenous aminophylline therapy for asthma. Am J Dis Child 134:596–599, 1980
Fox J, Hicks P, Feldman BR, Davis WJ, Feldman CH: Theophylline blood levels as a guide to intravenous therapy in children. Am J Dis Child 136:928–930, 1982
Coleman RW, Hedberg RL: Comparison of three methods for estimating theophylline pharmacokinetics. Clin Pharmacol 2:148–152, 1983
Mitsuoka JC, Fleck RJ: A system for individualized dosing of intravenous aminophylline using a programmable calculator. Pediatrics 73:64–67, 1984
Mungall D, Bancroft W, Marshall J: Computer-assisted oral and intravenous theophylline therapy. Computers Biomed Res 15:18–28, 1982
Kurland G, Mitsuoka C, Anderson D, Marguardt E: Work in progress
Carryer HM, Koelsche GA, Prickman LE, Magtum CK, Lake CF, Williams HL: The effect of cortisone in bronchial asthma and hay fever occurring in subject sensitive to ragweed pollen. Mayo Clin Proc 25:282–287, 1950
Siegel SC: Adrenal corticosteroids in the treatment of asthma. Clin Rev Allergy 1:123–146, 1983
Morris HG: Rational use of corticosteroid therapy. In Berman BA, MacDonnel KF (eds): Differential diagnosis and treatment of pediatric allergy. Boston, Little Brown, 1981, pp 267–284
Claman HN: Glucocorticosteroids I: Anti-inflammatory mechanisms. Hosp Pract 18:123–134, 1983
Claman HN: Glucocorticosteroids II: The clinical responses. Hosp Pract 18:143–151, 1983
Davis AD, Leftkowitz RJ: Agonist-promoted high affinity state of the 0-adrenergic receptor in human neutrophils: Modulation by corticosteroids. J Clin Endocrinol Metab 53:703–708, 1981
Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanism of action and clinical considerations. Ann Intern Med 84:304–315, 1976
Kattan M, Gurwitz D, Levison H: Corticosteroids in status asthmaticus. J Pediatr 96:596–599, 1980
Shapiro GG, Furukawa CT, Pierson WE, Gardinier R, Bierman CW: Double-blind evaluation of methylprednisolone versus placebo for acute asthma episodes. Pediatrics 71:510–514, 1983
Fanta CH, Rossing TH, McFadden ER Jr: Glucocorticosteroids in acute asthma. Am J Med 74:845–851, 1983
Luksza AR: Acute severe asthma treated without steroids. Br J Dis Chest 76:15–19, 1982
Grant IWB: Are corticosteroids necessary in the treatment of severe acute asthma? Br J Dis Chest 76:125–129, 1982
Collins JV, Harris PWR, Clark TJH, Townsend J: Intravenous corticosteroids in treatment of acute bronchial asthma. Lancet 2:1047–1049, 1970
Harfi H, Hanissian AS, Crawford LV: Treatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone. Pediatrics 61:829–831, 1978
American Academy of Pediatrics, Section on Allergy and Immunology: Management of asthma. Pediatrics 68:874–879, 1981
Chamberlin P, Meyer WJ III: Management of pituitary-adrenal suppression secondary to corticosteroid therapy. Pediatrics 67:245–250, 1981
Downes JJ, Wood DW, Harwood I, Sheinkopf HN, Raphaely RC: Intravenous isoproterenol infusion in children with severe hypercapnia due to status asthmaticus. Crit Care Med 1:63–68, 1973
Parry WH, Martorano F, Cotton EK: Management of life-threatening asthma with intravenous isoproterenol infusions. Am J Dis Child 130:39–42, 1976
Klaustermeyer W, DiBernardo R, Hale F: Intravenous isoproterenol: Rationale for bronchial asthma. J Allergy Clin Immunol 55:325–333, 1975
Kadac D, Tang HY, Conn AW: Isoproterenol metabolism in children after intravenous administration. Clin Pharmacol Ther 16:789–795, 1974
Kahn D, Rona G, Chappel C: Isoproterenol-induced cardiac necrosis. Ann NY Acad Sci 156:285–293, 1969
Matson J, Loughlin G, Strunk R: Myocardial ischemia complicating the use of isoproterenol in asthmatic children. J Pediatr 92:776–778, 1978
Kurland G, Williams J, Lewiston NJ: Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma. J Allergy Clin Immunol 63:407–411, 1979
Commentary: Interactions between methylxanthines and beta adrenergic agonists. FDA Bull 11:19–20, 1981
Novey HS: Cardiotoxicity of combined theophylline-beta adrenergic agonist therapy for asthma. Immunol Allergy Pract 5:208–211, 1983
Joseph X, Whitehurst VE, Bloom S, Galazs T: Enhancement of cardiotoxic effects of p-adrenergic bronchodilators by aminophylline in experimental animals. Fund Appl Toxicol 1:443, 1981
Whitehurst VE, Joseph X, Vick J, Balazs T: The influence of methylaxanthines on cardiotoxicity of isoproterenol in rats and minipigs. Toxicologist 3:53, 1983
Nicklas RA, Whitehurst VE, Donohoe RF, Balazs T: Concomitant use of beta adrenergic agonists and methylxanthines. J Allergy Clin Immunol 73:20–24, 1984
Herman JJ, Noah ZL, Moody RR: Use of intravenous isoproterenol for status asthmaticus in children. Crit Care Med 11:716–720, 1983
Hemstreet MP, Miles MV, Rutland RO: Effect of intravenous isoproterenol on theophylline kinetics. J Allergy Clin Immunol 69:360–364, 1982
O’Roarke PP, Crone RK: Effect of isoproterenol on measured theophylline levels. Crit Care Med 12:373–375, 1984
Perkin RM, Levin DL: Adverse effects of positive-pressure ventilation in children, in Gregory GA (ed): Respiratory failure in the child. New York, Churchill Livingstone, 1981, pp 163–187
Wood DW, Downes JJ, Leeks HI: The management of respiratory failure in childhood status asthmaticus. Experience with 30 episodes and evolution of a technique. J Allergy 42:261–267, 1968
Van Arsdale PP Jr: Adverse drug reactions. In Middleton E Jr, Reed CE, Ellis EF (eds): Allergy—Principles and practice. St. Louis, CV Mosby, 1978, pp 1133–1158
Klystra JA, Rausch DC, Hall KD, Spock A: Volume-controlled lung lavage in the treatment of asthma, bronchiectasis and mucoviscidosis. Am Rev Respir Dis 103:651–665, 1971
Rogers RM, Shuman JF, Zubrow AB: Bronchopulmonary lavage in bronchial asthma. Chest 63:62s-64s, 1973
Millman M, Goodman AH, Goldstein IM, Millman FM, Van Camper SS: Status asthmaticus: Use of acetylcysteine during bronchoscopy and lavage to remove mucous plugs. Ann Allergy 50:85–93, 1983
Eggleston PA, Ward BH, Pierson WE, Bierman CW: Radiographic abnormalities in acute asthma in children. Pediatrics 54:442–449, 1974
Brooks LJ, Cloutier MM, Afshani E: Significance of roentgenographic abnormalities in children hospitalized for asthma. Chest 82:315–318, 1982
Shapiro GG, Eggleston PA, Pierson WE, Ray CG, Bierman CW: Double-blind study of the effectiveness of a broad spectrum antibiotic in status asthmaticus. Pediatrics 53:867–872, 1974
Slavin RG: Relationship of nasal disease and sinusitis to bronchial asthma. Ann Allergy 49:76–80, 1982
Gelb AF, Lyons HA, Fairshter RD, Glauser FL, Morrissey R, Chetty K, Schiffman P: P pulmonale in status asthmaticus. J Allergy Clin Immunol 64:18–22, 1979
Hopkins IJ, Shield LK: Polomyelitis-like illness associated with asthma in childhood (Letters). Lancet 1:760, 1974
Mansion JI, Thong YH: Immunological abnormalities in the syndrome of poliomyelitis-like illness associated with acute bronchial asthma (Hopkins syndrome). Arch Dis Child 55:26–32, 1980
Editorial: Post-asthmatic psuedo-polio in children. Lancet 1:860, 1980
Paterson JW, Courtenay RJ, Prime FJ: Selectivity of bronchodilator action of salbutamol in asthmatic patients. Br J Dis Chest 65:21–38, 1971
Editorial: Intravenous versus inhaled salbutanol. Lancet 1:80, 1978
Lawford P, Jones BJM, Milledge A: Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J 1:84, 1978
Bloomfield P, Carmichael J, Petrie GR, Jewell NP, Crompton GK: Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J 1:848–850, 1979
Simons FER, Gillies JD: Dose response of subcutaneous terbulatine and epinephrine in children with acute asthma. Am J Dis Child 135:214–217, 1981.
Mathewson HS: Promising new bronchodilator drugs. Respir Ther 12:47–61, 1982
Gandevia B: Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J 50(Suppl 7): 13–20, 1975
Cavanaugh MJ, Cooper DM: Inhaled atropine sulfate: Dose response characteristics. Am Rev Respir Dis 114:517–524, 1975
Fairschter RD, Habib MP, Wilson AF: Inhaled atropine sulfate in acute asthma. Respiration 42:263–272, 1981
Pakes GE, Brodgen RN, Heel RC, Speight TM, Avery GS: Ipratropium bromide: A review of its pharmacologic properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20:237–266, 1980
Mann NP, Hiller EJ: Ipratropium bromide in children with asthma. Thorax 37:72–74, 1982
Ward MJ, Ferten PH, Smith WHR, Davies D: Ipratropium bromide in acute asthma. Br Med J 282:598–600, 1981
Elwood RK, Abboud RT: The short-term bronchodilator effects of fenoterol and ipratroprium in asthma. J Allergy Clin Immunol 69:467–473, 1982
Rebuck AS, Gent M, Chapman KR: Anticholinergic and sympathomimetic combination therapy of asthma. J Allergy Clin Immunol 71:317–323, 1983
Milner AD: Bronchodilator drugs in childhood asthma. Arch Dis Child 56:84–85, 1981
Hodges IGC, Groggins RC, Milner AD, Stokes GM: Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers. 56:729–732, 1981
Stokes GM, Milner AD, Hodges IGC, Henry RL, Elphick MC: Nebulised therapy in acute severe broncholitis in infancy. Arch Dis Child 58:279–283, 1983
McFadden ER Jr: Calcium-channel blocking agents and asthma. Ann Intern Med 95:232–233, 1981
Fanta CH, Drazen JM: Calcium blockers and bronchoconstriction. Am Rev Respir Dis 127:673–674, 1983
Barnes PJ, Wilson NM, Vickers H: Prazosin, an alpharadrenoceptor antagonist, partially inhibits exercise-induced asthma. J Allergy Clin Immunol 68:411–415, 1981
Shiner RJ, Molho MI: Comparison between an a-adrenergic antagonist and a p2-adrenergic agonist in bronchial asthma. Chest 83:602–606, 1983
Lewis RA, Austen KF: Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds. Nature 233:103–108, 1981
Marx JL: The leukotrienes in allergy and inflammation. Science 215:1380–1383, 1982
Hartman V, Magnussen H, Holle JP, Schuler E: Modulation of histamine-induced bronchoconstriction with inhaled, oral, and intravenous clemastine in normal and asthmatic subjects. Thorax 36:737–740, 1981
Henry RL, Hodges IGC, Milner AD, Stokes GM: Bronchodilator effects of the Hrreceptor antagonist—Clemastine. Arch Dis Child 8:304–305, 1983
Wanner A: The ideal bronchodilator. Arch Intern Med 139:399–400, 1979
McFadden ER Jr: The chronicity of acute attacks of asthma—Mechanical and therapeutic implications. J Allergy Clin Immunol 56:18–26, 1975
Kraemer R, Meister B, Schaad VB, Rossi E: Reversibility of lung function abnormalities in children with perennial asthma. J Pediatr 102:347–350, 1983
Mansmann HC Jr: Prevention of the continuum of bronchial asthma. J Pediatr 102:391, 1983
Kravis LP, Leeks HI, Wood DW, Greene JM, Rosen JP: Sudden death in childhood asthma. Adv Asthma/Allergy Pulm Dis 4:26–30, 1978 (Fisons Corp)
Richards W, Lew C, Carney J, Platzker A, Church JA: Review of intensive care unit admissions for asthma. Clin Pediatr 18:345–352, 1979
Mellis CM, Phelan PD: Asthma deaths in children—A continuing problem. Thorax 32:29–34, 1977
Tabachnik E, Levison H: Infantile bronchial asthma. J Allergy Clin Immunol 67:339–347, 1981
Matthews KP: Respiratory atopic disease. JAMA 248:2587–2610, 1982
Milner AD, Henry RL: Acute airways obstruction in children under 5. Thorax 37:641-645
Hodges IGC, Groggins RC, Milner AD, Stokes GM: Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers. Arch Dis Child 56:729–732, 1981
Stokes GM, Milner AD, Hodges IGC, Henry RL, Elphick MC: Nebulised therapy in acute severe bronchiolitis in infancy. Arch Dis Child 58:279–283, 1983
Fireman P, Friday GA, Gira C, Vierthaler WA, Michaels L: Teaching self-management skills to asthmatic children and their parents in an ambulatory care setting. Pediatrics 68:341–348, 1981
Richards W, Church JA: Self-help for asthmatic children. Respir Ther 12:45–50, 1982
Hindi-Alexander M, Cropp GJ: Community and family programs for children with asthma. Ann Allergy 46:143–148, 1981
King NJ: The behavioral management of asthma and asthma-related problems in children: A critical review of the literature. J Behav Med 3:169–189, 1980
Dahlem NW, Kinsman RA, Horton DJ: Requests for as-needed medications by asthmatic patients. Relationships to prescribed oral corticosteroid regimens and length of hospitalization. J Allergy Clin Immunol 63:23–27, 1979
Matus I: Assessing the nature and clinical significance of psychological contributions to childhood asthma. Am J Orthopsychiatry 51:327–341, 1981
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF02991192.
Rights and permissions
About this article
Cite this article
Kurland, G., Leong, A.B. The management of status asthmaticus in infants and children. Clin Rev Allergy 3, 37–67 (1985). https://doi.org/10.1007/BF02993042
Issue Date:
DOI: https://doi.org/10.1007/BF02993042